Search Results - "Balagon, M. V."

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    Prospective study of serological conversion as a risk factor for development of leprosy among household contacts by Douglas, J T, Cellona, R V, Fajardo, Jr, T T, Abalos, R M, Balagon, M V F, Klatser, P R

    “…Although the prevalence of leprosy has declined over the years, there is no evidence that incidence rates are falling. A method of early detection of those…”
    Get full text
    Journal Article
  2. 2

    Improvement in psoriasis after intradermal administration of delipidated, deglycolipidated Mycobacterium vaccae (PVAC™): results of an open-label trial by Balagon, M. V., Tan, P. L., Prestidge, R., Cellona, R. V., Abalos, R. M., Tan, E. V., Walsh, G. P., Watson, J. D., Walsh, D. S.

    Published in Clinical and experimental dermatology (01-05-2001)
    “…The aim of new treatments for psoriasis is to induce extended remissions with fewer side‐effects. Previous studies suggest that Mycobacterium vaccae, a…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Multiple lesions of sporotrichoid leishmaniasis in a Filipino expatriate by Walsh, Douglas S., Balagon, Maria V., Abalos, Rodolfo M., Tiongco, Estrelitta S., Cellona, Roland V., Fajardo, Tranquilino T., Walsh, Gerald P.

    “…Sporotrichoid cutaneous leishmaniasis (CL) was diagnosed in a Filipino man who had worked in Saudi Arabia for 2 years. Two primary lesions—one on the forearm…”
    Get full text
    Journal Article
  5. 5

    Improvement in psoriasis after intradermal administration of heat-killed Mycobacterium vaccae by Balagon, Maria V., Walsh, Douglas S., Tan, Paul L., Cellona, Roland V., Abalos, Rodolfo M., Tan, Esterlina V., Fajardo Jr, Tranquilino T., Watson, James D., Walsh, Gerald P.

    Published in International journal of dermatology (01-01-2000)
    “…Background New treatments for psoriasis are being developed, but many are associated with limited efficacy, side‐effects, or rapid recurrence after…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Cutaneous delayed-type hypersensitivity responsiveness in lepromatous and borderline lepromatous leprosy patients as determined by MULTITEST® CMI by WALSH, D. S, VILLAHERMOSA, L. G, BALAGON, M. V, ABALOS, R. M, FAJARDO, T. T, TAN, E. V, CELLONA, R. V, WALSH, G. P

    “…To assess cell mediated immune (CMI) function in patients with lepromatous and borderline lepromatous leprosy (LL and BL), 35 patients were examined with the…”
    Get full text
    Journal Article
  10. 10

    Primary dapsone resistance in Cebu, The Philippines; cause for concern by dela Cruz, E, Cellona, R V, Balagon, M V, Villahermosa, L G, Fajardo, Jr, T T, Abalos, R M, Tan, E V, Walsh, G P

    “…At a time when primary dapsone resistance was prevalent in many leprosy endemic areas, Cebu in The Philippines reported only 3.6% in the period 1975-1978 and…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy by Cho, S N, Cellona, R V, Villahermosa, L G, Fajardo, Jr, T T, Balagon, M V, Abalos, R M, Tan, E V, Walsh, G P, Kim, J D, Brennan, P J

    “…A total of 100 untreated new leprosy patients were recruited prospectively and examined for the presence of phenolic glycolipid I (PGL-I) antigen in their…”
    Get full text
    Journal Article
  18. 18